Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-006720
Filing Date
2021-06-15
Accepted
2021-06-15 17:15:43
Documents
2
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1655
2 ex24_smith.htm EX-24 8008
  Complete submission text file 0001179110-21-006720.txt   11122
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Smith Mary L. (Reporting) CIK: 0001866044 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35969 | Film No.: 211019575